Trueblood Wealth Management’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Buy
4,108
+430
+12% +$49.3K 0.18% 157
2026
Q1
$404K Sell
3,678
-68
-2% -$7.71K 0.16% 172
2025
Q4
$426K Buy
3,746
+229
+7% +$26K 0.17% 169
2025
Q3
$386K Buy
3,517
+257
+8% +$26.9K 0.15% 176
2025
Q2
$338K Buy
3,260
+2
+0.1% +$201 0.14% 189
2025
Q1
$338K Hold
3,258
0.16% 172
2024
Q4
$339K Buy
3,258
+470
+17% +$51K 0.17% 170
2024
Q3
$312K Hold
2,788
0.16% 174
2024
Q2
$291K Hold
2,788
0.16% 167
2024
Q1
$306K Hold
2,788
0.18% 152
2023
Q4
$289K Buy
+2,788
New +$269K 0.18% 159

Other funds holding FXH

Trueblood Wealth Management's FXH Position: Q2 2026 in Review

Trueblood Wealth Management increased its First Trust Health Care AlphaDEX Fund (FXH) stake by 12% in Q2 2026, buying an estimated $49.3K and bringing the position to 4,108 shares worth $503K. The position accounts for 0.18% of the portfolio, ranked #157.

Trueblood Wealth Management first reported a position in FXH in Q4 2023 and has held it in 11 quarters since. 252 funds tracked by Wall St. Rank hold FXH as of Q2 2026.

  • Trueblood Wealth Management held 4,108 shares of First Trust Health Care AlphaDEX Fund worth $503K as of Q2 2026.
  • Trueblood Wealth Management bought 430 First Trust Health Care AlphaDEX Fund shares in Q2 2026, an estimated $49.3K.
  • First Trust Health Care AlphaDEX Fund made up 0.18% of Trueblood Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Trueblood Wealth Management first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2023 and has held it in 11 quarters since.
  • 252 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.